$232 Million is the total value of SALEM CAPITAL MANAGEMENT INC's 76 reported holdings in Q4 2013. The portfolio turnover from Q3 2013 to Q4 2013 was 13.3% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
UL | Buy | Unilever PLC ADR | $7,786,000 | +7.4% | 188,976 | +0.6% | 3.36% | +0.8% |
WY | Buy | Weyerhaeuser Co. | $7,639,000 | +10.7% | 241,982 | +0.4% | 3.30% | +3.8% |
PFE | Buy | Pfizer Inc. | $6,708,000 | +7.1% | 219,010 | +0.4% | 2.90% | +0.5% |
MRK | Buy | Merck & Co. | $6,695,000 | +6.1% | 133,776 | +0.9% | 2.89% | -0.4% |
IP | Buy | International Paper | $6,575,000 | +10.0% | 134,100 | +0.5% | 2.84% | +3.2% |
GSK | Buy | Glaxo Smithkline PLC-Spon ADR | $6,464,000 | +6.6% | 121,075 | +0.2% | 2.79% | +0.0% |
DOW | Buy | Dow Chemical | $6,310,000 | +18.4% | 142,125 | +2.4% | 2.72% | +11.1% |
MRO | Buy | Marathon Oil Corp. | $6,305,000 | +1.2% | 178,625 | +0.0% | 2.72% | -5.0% |
HTZ | New | Hertz Global Holdings Inc. | $5,272,000 | – | 184,200 | +100.0% | 2.28% | – |
CSCO | Buy | Cisco Systems | $5,037,000 | +3.1% | 224,550 | +6.9% | 2.17% | -3.3% |
EMC | Buy | EMC Corp. | $4,594,000 | +4.4% | 182,660 | +6.1% | 1.98% | -2.1% |
ABBV | Buy | AbbVie Inc. | $2,980,000 | +19.5% | 56,425 | +1.2% | 1.29% | +12.1% |
PCL | Buy | Plum Creek Timber | $2,060,000 | +67.9% | 44,300 | +69.1% | 0.89% | +57.6% |
T | Buy | AT & T Corp. | $850,000 | +8.0% | 24,167 | +3.9% | 0.37% | +1.4% |
DOV | Buy | Dover Corp | $635,000 | +82.5% | 6,575 | +69.7% | 0.27% | +71.2% |
ESRX | New | Express Scripts | $205,000 | – | 2,922 | +100.0% | 0.09% | – |
ISCIQ | Buy | ISC8 Inc. | $2,000 | +100.0% | 79,311 | +170.6% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-01-23
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
Microsoft | 38 | Q3 2022 | 8.6% |
Honeywell Int'l | 38 | Q3 2022 | 5.5% |
Merck & Co. | 38 | Q3 2022 | 5.6% |
Weyerhaeuser Co. | 38 | Q3 2022 | 4.8% |
Cisco Systems | 38 | Q3 2022 | 5.3% |
Johnson & Johnson | 38 | Q3 2022 | 5.1% |
Pfizer Inc. | 38 | Q3 2022 | 5.3% |
International Paper | 38 | Q3 2022 | 4.6% |
CVS Health Corporation | 38 | Q3 2022 | 5.6% |
Verizon Communications | 38 | Q3 2022 | 3.1% |
View SALEM CAPITAL MANAGEMENT INC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2022-11-29 |
13F-HR | 2022-07-27 |
13F-HR | 2022-04-07 |
13F-HR | 2022-01-18 |
13F-HR | 2021-10-12 |
13F-HR | 2021-07-13 |
13F-HR | 2021-04-15 |
13F-HR | 2021-01-12 |
13F-HR | 2020-10-13 |
13F-HR | 2020-07-20 |
View SALEM CAPITAL MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.